Literature DB >> 19224297

Results of completion gastrectomies in 44 patients with postsurgical gastric atony.

James E Speicher1, Richard C Thirlby, Joseph Burggraaf, Christopher Kelly, Sarah Levasseur.   

Abstract

INTRODUCTION: Postsurgical gastric atony occurs infrequently after gastric surgery. However, the symptoms are disabling and refractory to medical management. The only effective treatment is completion gastrectomy. A few studies have examined in detail the long-term results of this radical procedure.
METHODS: From 1988 through 2007, 44 patients (84% female, 16% male) underwent near-total or total completion gastrectomies for refractory postsurgical gastric atony. The average age was 52 (range 32-72). Gastric atony was documented using radionuclide solid food emptying studies. Charts were reviewed retrospectively to identify preoperative symptoms and long-term postoperative function, and the patients were contacted by phone to evaluate their current level of function.
RESULTS: Of the original 44 patients, 66% (n = 29) were evaluated postoperatively at a mean of 5.6 + 4.5 years (range 0.5-15.0 years). Fourteen patients (32%) had died, and seven (16%) were lost to follow-up. Most common presenting symptoms were abdominal pain (98%), vomiting (98%), nausea (77%), diet limitation (75%), heartburn (64%), and weight loss (59%, average = 19% of BW). Postoperative complications occurred in 36% (n = 16), most commonly bowel obstruction (11%), anastomotic stricture (9%), and anastomotic leak (7%), and there was one perioperative death. At last follow-up, there were significant improvements in abdominal pain (97% to 59%, p < 0.001), vomiting (97% to 31%, p < 0.001), nausea (86% to 45%, p < 0.001), and diet limited to liquids or nothing at all (57% to 7%, p < 0.001). Some symptoms were more common postoperatively, including early satiety (24% to 89%, p < 0.001), and postprandial fullness (10% to 72%, p < 0.001). Average BMI at the time of surgery and at last follow-up were 23 and 21, respectively. Osteoporosis was diagnosed pre- and postoperatively in 17% and 67% of patients, respectively (p < 0.001). Seventy-eight percent of patients stated that they were in better health after surgery, while 17% were neutral, and 6% stated that they were worse off. Mean satisfaction with surgery was 4.7 (1-5 Likert scale).
CONCLUSION: Completion gastrectomies in this patient population resulted in significant improvements in abdominal pain, vomiting, nausea, and severe diet limitations. Most patients, however, have significant ongoing gastrointestinal complaints, and the incidence of osteoporosis is high. Patient satisfaction is high; about 78% of patients believed their health status is improved. We believe these data support the selective use of completion gastrectomies in patients with severe postsurgical gastroparesis.

Entities:  

Mesh:

Year:  2009        PMID: 19224297     DOI: 10.1007/s11605-009-0821-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  29 in total

Review 1.  Current problems in surgery: gastric cancer.

Authors:  Clancy J Clark; Richard C Thirlby; Vicent Picozzi; Drew B Schembre; Felicia P Cummings; Eugene Lin
Journal:  Curr Probl Surg       Date:  2006 Aug-Sep       Impact factor: 1.909

2.  Roux-Y gastrectomy for chronic gastric atony.

Authors:  L Karlstrom; K A Kelly
Journal:  Am J Surg       Date:  1989-01       Impact factor: 2.565

3.  Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis.

Authors:  F Azpiroz; J R Malagelada
Journal:  Gastroenterology       Date:  1987-04       Impact factor: 22.682

4.  Alkaline reflux gastritis and the effect of biliary diversion on gastric emptying of solid food.

Authors:  C A Pellegrini; M G Patti; M Lewin; L W Way
Journal:  Am J Surg       Date:  1985-07       Impact factor: 2.565

5.  The value of sham-feeding tests in patients with postgastrectomy syndromes.

Authors:  B G Bradshaw; R C Thirlby
Journal:  Arch Surg       Date:  1993-09

6.  Long-term outcome of completion gastrectomy for nonmalignant disease.

Authors:  M Farahmand; B C Sheppard; C W Deveney; K E Deveney; R A Crass
Journal:  J Gastrointest Surg       Date:  1997 Mar-Apr       Impact factor: 3.452

7.  Safety and long-term durability of completion gastrectomy in 81 patients with postsurgical gastroparesis syndrome.

Authors:  F E Eckhauser; M Conrad; J A Knol; M W Mulholland; L M Colletti
Journal:  Am Surg       Date:  1998-08       Impact factor: 0.688

8.  Gastric emptying and clinical outcome after Roux-en-Y diversion.

Authors:  J P Britton; D Johnston; D C Ward; A T Axon; M C Barker
Journal:  Br J Surg       Date:  1987-10       Impact factor: 6.939

9.  Laparoscopic vs open gastric bypass in the management of morbid obesity: a 7-year retrospective study of 1,364 patients from a single center.

Authors:  Emmanuel Atta Agaba; Hazem Shamseddeen; Charmaine Victoria Gentles; Venketesh Sasthakonar; Larry Gellman; Dominick Gadaleta
Journal:  Obes Surg       Date:  2008-04-26       Impact factor: 4.129

10.  Near-total completion gastrectomy for severe postvagotomy gastric stasis: analysis of early and long-term results in 62 patients.

Authors:  A W Forstner-Barthell; M M Murr; S Nitecki; M Camilleri; C M Prather; K A Kelly; M G Sarr
Journal:  J Gastrointest Surg       Date:  1999 Jan-Feb       Impact factor: 3.267

View more
  12 in total

1.  Per-Oral Pyloromyotomy (POP) for Medically Refractory Post-Surgical Gastroparesis.

Authors:  Andrew T Strong; Joshua P Landreneau; Michael Cline; Matthew D Kroh; John H Rodriguez; Jeffrey L Ponsky; Kevin El-Hayek
Journal:  J Gastrointest Surg       Date:  2019-02-26       Impact factor: 3.452

Review 2.  Gastroparesis: pathogenesis, diagnosis and management.

Authors:  William L Hasler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-19       Impact factor: 46.802

3.  Evaluation of gastrectomy in patients with delayed gastric emptying after antireflux surgery or large hiatal hernia repair.

Authors:  Arja Gerritsen; Edgar J B Furnée; Hein G Gooszen; Maurits Wondergem; Eric J Hazebroek
Journal:  World J Surg       Date:  2013-05       Impact factor: 3.352

4.  Gastrectomy versus stomach left in situ with Roux-en-Y reconstruction for the treatment of gastroparesis.

Authors:  Joshua P Landreneau; Andrew T Strong; Kevin El-Hayek; Matthew D Kroh; John H Rodriguez
Journal:  Surg Endosc       Date:  2019-07-11       Impact factor: 4.584

5.  Endoscopic intrapyloric injection of botulinum toxin A in the treatment of children with gastroparesis: a retrospective, open-label study.

Authors:  Leonel Rodriguez; Rachel Rosen; Michael Manfredi; Samuel Nurko
Journal:  Gastrointest Endosc       Date:  2012-02       Impact factor: 9.427

6.  Does gastric resection have a role in the management of severe postfundoplication gastric dysfunction?

Authors:  Clancy J Clark; Michael G Sarr; Amindra S Arora; Francis C Nichols; Kaye M Reid-Lombardo
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

7.  Surgical treatment of medically refractory gastroparesis in the morbidly obese.

Authors:  Zhuo Sun; John Rodriguez; John McMichael; Bipan Chand; Deanne Nash; Stacy Brethauer; Phillip Schauer; Kevin El-Hayek; Matthew Kroh
Journal:  Surg Endosc       Date:  2015-01-17       Impact factor: 4.584

8.  Exceptionally rare cause of a total stomach resection.

Authors:  Jadwiga Snarska; Krzysztof Jacyna; Jacek Janiszewski; Danuta Shafie; Katarzyna Iwanowicz; Anna Żurada
Journal:  World J Gastroenterol       Date:  2012-05-28       Impact factor: 5.742

9.  End of the road for a dysfunctional end organ: laparoscopic gastrectomy for refractory gastroparesis.

Authors:  Neil H Bhayani; Ahmed M Sharata; Christy M Dunst; Ashwin A Kurian; Kevin M Reavis; Lee L Swanstrom
Journal:  J Gastrointest Surg       Date:  2015-01-10       Impact factor: 3.452

10.  Gastric electric stimulator versus gastrectomy for the treatment of medically refractory gastroparesis.

Authors:  Jamil S Samaan; Omar Toubat; Evan T Alicuben; Sean Dewberry; Adrian Dobrowolski; Kulmeet Sandhu; Joerg Zehetner; John C Lipham; Kamran Samakar
Journal:  Surg Endosc       Date:  2022-03-25       Impact factor: 3.453

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.